Navigation Links
Transfection Technologies Market is Growing at an Estimated CAGR of 9.32% & to Reach $601 Million by 2017- MarketsandMarkets
Date:1/20/2013

or in the transfection technology market. The market is segmented based on the technologies, where Bio-chemical based methods hold the major share in the market because of its cost advantage and simplicity over other technologies. Physical based methods are growing at a healthy pace because of its ability to transfect hard to transfect cells, while the viral mediated methods are growing at a steady phase.

The key growth area of transfection products is the application in therapeutic area, where transfection is effectively used in treatment of cancer and other genetic disorders. Growth in gene therapy is also driving the transfection market. Gene therapy promises to cure various diseases and disorders, and is one of the growing application in therapeutic segments with four approved drugs being in market. Electrochemotherapy is another upcoming therapeutic method being tested widely in Europe and America for treating cutaneous and sub-cutaneous tumors.

The global market for transfection products was estimated to be worth US $385 million in 2012 and is expected to reach US $601 million by 2017, growing at a CAGR of 9.32% from 2012 to 2017.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electro
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. When Can You Get Pregnant? Many Women Don’t Know, But a Simple Family Planning Method Now Available from Cycle Technologies Can Help
2. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
3. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
4. National Academy of Inventors inaugural conference highlights innovative technologies
5. Application Development Firm Anahata Technologies Pty Ltd Announces GlassFish as Application Server of Choice
6. Application Development Company Anahata Technologies Announces CentOS As Server OS Of Choice For Enterprise Applications
7. Anahata Technologies Pty Ltd Announces Software Development Partnership with MYOB
8. The Life Support Technologies Group Announces 2013 Hyperbaric Medical Training Course Dates
9. Anahata Technologies to Offer Custom Software Solution Development Services for Small and Medium Businesses in 2013
10. Application Development Services Provider Anahata Technologies Reviews 2012 Exercise, Sets 100% Customer Satisfaction Goal for 2013
11. Application Development Firm Anahata Technologies Pty Ltd Announces JavaFX 2.0 as Technology of Choice for Enterprise Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... from Boston University School of Medicine (BUSM) and ... who received care through BMC,s Violence Intervention Advocacy ... emotional and social needs of violently injured youthswere ... experienced life changing behaviors through connections to caring, ... and hope. These findings are reported in the ...
(Date:7/22/2014)... from the Sloan-Kettering Institute for Cancer Research in New ... Schools of Medicine and Dentistry have completed research which ... how some cells in the brain and nervous system ... published in the prestigious journal Cancer Cell . ... a tumour suppressor called Merlin. , The results ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 BlogHer, ... for women, this year celebrates its tenth anniversary where ... Thousands of attendees, including community leaders from the new ... representing every consumer vertical, will converge in San Jose ... conversation, and a “selfiebration” of social technology. , ...
(Date:7/22/2014)... SWAMP , the first ... has completed an upgrade that significantly improves the ... with a $23.4 million grant from the ... (DHS S&T), the Software Assurance Marketplace (SWAMP) ... to assess the security of their software, but ...
(Date:7/22/2014)... New study findings released today confirm ... patient-centered program is working to improve the coordination of ... the largest to date and includes more than 200,000 ... that focuses on delivering better quality outcomes, a better ... , “Our most recent study results clearly demonstrate the ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Research brings us nearer to understanding how neuro cells turn cancerous 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 2Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 3Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 4Health News:The SoftWare Assurance MarketPlace (SWAMP) Gains Industry Momentum With Significantly Improved Interface Enhancements 5Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 2Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 3
... Global health organization PSI helps contestants spread HIV prevention ... Bahamas, Aug. 21 The Miss Universe contestants continued preparations for ... tossing water-filled condoms to test their strength and playing "Wild Fire ... The games are part of an HIV peer education workshop designed ...
... ... Mesothelioma Patients , ... Newton, MA (PRWEB) August 21, 2009 -- MesoRC.com, an online community and resource center ... diseases, provides an extra source of valuable information with the introduction of Twitter. The ...
... , , LOS ANGELES, Aug. ... the launch of Energy-X, a new lip balm that delivers an effective ... sweeteners. With zero calories, Energy-X provides the energy boost consumers want without ... "Energy-X is applied directly on the lips and is therefore ...
... , , , ... to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at ... , 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 ... price of 1 tickets. , , The concert features ...
... treating a recurrent or residual brain aneurysm that was ... a multicenter study led by researchers at the University ... of 311 patients with coiled aneurysms who underwent retreatment ... death or permanent major disability was slightly over one ...
... , FRAMINGHAM, Mass. and SYDNEY, Aug. ... announced that HeartWare has surpassed 50 implants in the United States ... , , The 50th implant in the ... Houston, Texas by O.H. Frazier, MD a distinguished surgeon, scientist, and ...
Cached Medicine News:Health News:Miss Universe Contestants Enter Condom Olympics to Tackle HIV 2Health News:Miss Universe Contestants Enter Condom Olympics to Tackle HIV 3Health News:Mesothelioma Resource Center Enters Twitter World 2Health News:Energy-X Lip Balm Delivers Wake-Up Call to Consumers 2Health News:The Sensory Research Center (SRC) Offers 2 for 1 Tickets for Benefit Concert Supporting Autism, Down's Syndrome, Cerebral Palsy and Other Disabilities. 2Health News:Study finds low risk in treating previously coiled aneurysm 2Health News:Study finds low risk in treating previously coiled aneurysm 3Health News:HeartWare International Surpasses 50 Implants in the US 2Health News:HeartWare International Surpasses 50 Implants in the US 3
(Date:7/22/2014)... Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and ... lots of Fluzone ® (Influenza Vaccine) for the 2014-2015 ... Food and Drug Administration (FDA) for distribution. The lots were ... least 65 million doses of seasonal influenza vaccine manufactured by ... providers and pharmacies in August. The U.S. ...
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
(Date:7/22/2014)... 22, 2014 The Intellectual ... , the world,s leading provider of intelligent ... Cortellis Clinical Trials Intelligence , its ... milestone with the documentation of more than ... with greater and quicker access to critical ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3
...  InterMune, Inc. (NADSAQ: ITMN) today reported that ... its decision granting the additional benefit of ... of mild-to-moderate idiopathic pulmonary fibrosis (IPF).  Esbriet,s ... (not quantifiable benefit)  in the rating system ...
... Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China ... China, today announced financial results for the year ended December ... , Revenue increased 9% to $81.2 million in fiscal ... , Income from operations was $22.0 million in fiscal year ...
Cached Medicine Technology:Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 2Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 3Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 4Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 5Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 2China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 3China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 4China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 5China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 7China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 8China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 9China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 10China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 11China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 12
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
... modified battery chargers are ... for GENIE blotters. They ... very specific voltages, giving ... laboratory power supplies. 110 ...
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
Inquire...
Medicine Products: